Two Sigma Investments’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.32M | Buy |
408,195
+109,771
| +37% | +$894K | 0.01% | 1469 |
|
|
2025
Q1 | $2.34M | Buy |
298,424
+151,738
| +103% | +$1.19M | 0.01% | 1592 |
|
|
2024
Q4 | $2.18M | Buy |
146,686
+11,027
| +8% | +$164K | ﹤0.01% | 1593 |
|
|
2024
Q3 | $2.07M | Buy |
135,659
+30,531
| +29% | +$467K | ﹤0.01% | 1606 |
|
|
2024
Q2 | $1.6M | Sell |
105,128
-158,149
| -60% | -$2.41M | ﹤0.01% | 1632 |
|
|
2024
Q1 | $4.97M | Buy |
263,277
+150,204
| +133% | +$2.84M | 0.01% | 928 |
|
|
2023
Q4 | $2.16M | Buy |
113,073
+70,858
| +168% | +$1.35M | 0.01% | 1407 |
|
|
2023
Q3 | $758K | Buy |
+42,215
| New | +$758K | ﹤0.01% | 2012 |
|
|
2022
Q4 | – | Sell |
-49,891
| Closed | -$1.31M | – | 2970 |
|
|
2022
Q3 | $1.31M | Buy |
+49,891
| New | +$1.31M | ﹤0.01% | 1310 |
|
|
2022
Q1 | – | Sell |
-160,336
| Closed | -$6.49M | – | 3018 |
|
|
2021
Q4 | $6.49M | Buy |
160,336
+91,891
| +134% | +$3.72M | 0.01% | 812 |
|
|
2021
Q3 | $2.39M | Sell |
68,445
-69,307
| -50% | -$2.42M | 0.01% | 1264 |
|
|
2021
Q2 | $3.78M | Buy |
137,752
+103,883
| +307% | +$2.85M | 0.01% | 1036 |
|
|
2021
Q1 | $951K | Sell |
33,869
-170,364
| -83% | -$4.78M | ﹤0.01% | 1624 |
|
|
2020
Q4 | $5.3M | Sell |
204,233
-387,713
| -65% | -$10.1M | 0.02% | 711 |
|
|
2020
Q3 | $10.1M | Buy |
591,946
+224,628
| +61% | +$3.85M | 0.04% | 421 |
|
|
2020
Q2 | $9.09M | Buy |
367,318
+313,047
| +577% | +$7.74M | 0.05% | 360 |
|
|
2020
Q1 | $753K | Sell |
54,271
-70,702
| -57% | -$981K | 0.01% | 1090 |
|
|
2019
Q4 | $1.26M | Buy |
124,973
+92,123
| +280% | +$930K | ﹤0.01% | 1303 |
|
|
2019
Q3 | $299K | Sell |
32,850
-11,033
| -25% | -$100K | ﹤0.01% | 1643 |
|
|
2019
Q2 | $349K | Buy |
+43,883
| New | +$349K | ﹤0.01% | 1707 |
|